Control and Elimination of Hepatitis C Virus Among People With HIV in Australia: Extended Follow-up of the CEASE Cohort (2014–2023)
Universal access and rapid DAA uptake were associated with a dramatic reduction in HCV prevalence and reinfection incidence among people with HIV to levels consistent with microelimination. <b>Registration:</b> NCT02102451 (ClinicalTrials.gov).
Authors
- Margaret Elena Hellard (ORCID: https://orcid.org/0000-0002-5055-3266)
- Samira Hosseini‐Hooshyar (ORCID: https://orcid.org/0000-0001-8614-9129)
- Ecaterina Filep
- Joanne Carson (ORCID: https://orcid.org/0000-0001-8043-0200)
- Jeffrey J. Post (ORCID: https://orcid.org/0000-0003-1475-9272)
- Robert Finlayson (ORCID: https://orcid.org/0000-0002-9981-632X)
- Phillip J. Read (ORCID: https://orcid.org/0000-0001-5422-3777)
- Joseph Doyle (ORCID: https://orcid.org/0000-0001-7198-0833)
- Gregory J. Dore (ORCID: https://orcid.org/0000-0002-4741-2622)
- Gail Matthews (ORCID: https://orcid.org/0000-0002-1048-6396)
- Marianne Martinello (ORCID: https://orcid.org/0000-0001-9444-0186)
- David Shaw (ORCID: https://orcid.org/0000-0002-9359-050X)
- David Baker
- Mark Bloch
Institutions
- Royal Adelaide Hospital (AU)
- Burnet Institute (AU)
- The Alfred Hospital (AU)
- UNSW Sydney (AU)
- St Vincent's Hospital Sydney (AU)
- Albion Centre (AU)
- Prince of Wales Hospital (AU)
- Doctors Hospital (US)
- Kirklin Clinic (US)
Publication Details
- Journal
- Open Forum Infectious Diseases
- Published
- 2024-11-27
- DOI
- https://doi.org/10.1093/ofid/ofae665
- Citations
- 4
- Primary Topic
- Hepatitis C virus research
- Type
- article
- Field-Weighted Citation Impact
- 1.48
Funders
- Gilead Sciences
- Department of Health and Ageing, Australian Government